New drug combo aims to spare seniors from colorectal cancer surgery
NCT ID NCT06205836
Summary
This study is testing whether immunotherapy drugs (cemiplimab with or without fianlimab) can effectively treat a specific type of colorectal cancer in patients aged 70 and older, or in adults who are poor candidates for surgery. The main goal is to see if the treatment can completely eliminate the cancer, potentially allowing patients to avoid major surgery. Researchers will closely monitor participants for two years to check the treatment's effectiveness and safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Johns Hopkins SKCCC
RECRUITINGBaltimore, Maryland, 21231, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.